TITLE

Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy

AUTHOR(S)
Guojun Chen; Yali Wang; Zhenyu Xu; Feng Fang; Renmei Xu; Yue Wang; Xiaoli Hu; Lixing Fan; Houqi Liu
PUB. DATE
March 2013
SOURCE
Journal of Translational Medicine;2013, Vol. 11 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children. Autologous MSCs may be a better cell source and have been studied for the treatment of cerebral palsy because of their functions in tissue repair and the regulation of immunological processes. Methods: To assess neural stem cell-like (NSC-like) cells derived from autologous marrow mesenchymal stem cells as a novel treatment for patients with moderate-to-severe cerebral palsy, a total of 60 cerebral palsy patients were enrolled in this open-label, non-randomised, observer-blinded controlled clinical study with a 6-months follow-up. For the transplantation group, a total of 30 cerebral palsy patients received an autologous NSC-like cells transplantation (1-2 × 107 cells into the subarachnoid cavity) and rehabilitation treatments whereas 30 patients in the control group only received rehabilitation treatment. Results: We recorded the gross motor function measurement scores, language quotients, and adverse events up to 6 months post-treatment. The gross motor function measurement scores in the transplantation group were significantly higher at month 3 (the score increase was 42.6, 95% CI: 9.8-75.3, P=.011) and month 6 (the score increase was 58.6, 95% CI: 25.8-91.4, P=.001) post-treatment compared with the baseline scores. The increase in the Gross Motor Function Measurement scores in the control group was not significant. The increases in the language quotients at months 1, 3, and 6 post-treatment were not statistically significant when compared with the baseline quotients in both groups. All the 60 patients survived, and none of the patients experienced serious adverse events or complications. Conclusion: Our results indicated that NSC-like cells are safe and effective for the treatment of motor deficits related to cerebral palsy. Further randomised clinical trials are necessary to establish the efficacy of this procedure.
ACCESSION #
85955444

 

Related Articles

  • Fetal membranes as a source of stem cells. Kmiecik, G.; Niklińska, W.; Kuć, P.; Pancewicz-Wojtkiewicz, J.; Fil, D.; Karwowska, A.; Karczewski, J.; Mackiewicz, Z. // Advances in Medical Sciences (De Gruyter Open);2013, Vol. 58 Issue 2, p185 

    In recent years, a constant growth of knowledge and clinical applications of stem cells have been observed. Mesenchymal stromal cells, also described as mesenchymal stem cells (MSCs) represent a particular cell type for research and therapy because of their ability to differentiate into...

  • Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? Plock, Jan A.; Schnider, Jonas T.; Schweizer, Riccardo; Gorantla, Vijay S.; Bondanza, Attilio; Biagi, Ettore // Frontiers in Immunology;Feb2013, Vol. 4, Special section p1 

    The article discusses a study by E. Eggenhofer and colleagues published in an issue of "Frontiers in Immunology" on the role of cultured mesenchymal stromal cells (MSCs) in immunomodulation in transplantation. The researchers presented evidence in a mouse model that cultured bone-marrow derived...

  • Hydrodynamic loading in concomitance with exogenous cytokine stimulation modulates differentiation of bovine mesenchymal stem cells towards osteochondral lineages. Goldman, Stephen M.; Barabino, Gilda A. // BMC Biotechnology;2/1/2016, Vol. 16, p1 

    Background: Mesenchymal stem cells (MSCs) are viewed as a having significant potential for tissue engineering and regenerative medicine therapies. Clinical implementation of MSCs, however, demands that their preparation be stable and reproducible. Given that environmental and bioprocessing...

  • Proteomic analysis of the impact of static culturing on the expansion of rat bone marrow mesenchymal stem cells. Peter, Stefan; Evans, Caroline; Ow, Saw; Scutt, Andy; Wright, Phillip; Biggs, Catherine // Biotechnology Letters;Aug2012, Vol. 34 Issue 8, p1589 

    The clinical potential of mesenchymal stem cells (MSC) in tissue engineering and regenerative medicine is due to their self-renewal, proliferation and multi-lineage differentiation potential. Clinical use requires large cell numbers; which can, theoretically, be generated by ex vivo expansion of...

  • The Therapeutic Effects of Bone Marrow-Derived Mesenchymal Stem Cells and Simvastatin in a Rat Model of Liver Fibrosis. Motawi, Tarek; Atta, Hazem; Sadik, Nermin; Azzam, May // Cell Biochemistry & Biophysics;Jan2014, Vol. 68 Issue 1, p111 

    Liver fibrosis is the excessive accumulation of extracellular matrix (ECM) proteins including collagen that occurs in most types of chronic liver diseases. Studies concerning the capacity of mesenchymal stem cells (MSCs) and simvasatain (SIMV) to repair fibrotic tissues through reducing...

  • Effect of nuclear receptor corepressor on bone marrow mesenchymal stem cells proliferation. Hongwei Gao; Deguo Xing; Liang Wang; Lan Liu; Zhonghao Liu; Mingzhi Gong // International Journal of Clinical & Experimental Medicine;2016, Vol. 9 Issue 7, p13965 

    Objective: Bone marrow mesenchymal stem cells (BMSCs) are considered a promising cell source for tissue engineering. Methods to advance the proliferation and anti-apoptotic capacity of mesenchymal stem cells (MSCs) are required to improve the efficiency of MSC-based therapy. In this study, we...

  • Cell therapy for cerebral hemorrhage: Five year follow-up report. ZHITIAN CHANG; GENGSHENG MAO; LIZHONG SUN; QIANG AO; YONGQUAN GU; YING LIU // Experimental & Therapeutic Medicine;Dec2016, Vol. 12 Issue 6, p3535 

    The aim of the study was to examine treatment of cerebral hemorrhages with bone-marrow or human umbilical cord-derived mesenchymal stem cells (BMSCs or Hu-MSCs) and conventional surgical approaches, and determine and compare the effectiveness, feasibility, safety and reproducibility of each...

  • Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation. Yang Tian; Jingcheng Wang; Wei Wang; Yuan Ding; Zhongquan Sun; Qiyi Zhang; Yan Wang; Haiyang Xie; Sheng Yan; Shusen Zheng // Stem Cell Research & Therapy;10/27/2016, Vol. 7, p1 

    Background: Liver transplantation is the optimal treatment option for end-stage liver disease, but organ shortages dramatically restrict its application. Donation after cardiac death (DCD) is an alternative approach that may expand the donor pool, but it faces challenges such as graft...

  • Immunoregulatory role of chimerism in clinical organ transplantation. Mathew, J M; Miller, J // Bone Marrow Transplantation;7/15/2001, Vol. 28 Issue 2, p115 

    Editorial. Comments on the immunoregulatory role of chimerism in clinical organ transplantation. History of the infusions of stem cells and other bone marrow-derived cells; Controversy of chimerism; Detection of chimerism.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics